Strong Revenue Trends And Better Prospects Make Penumbra Stock A Good Bet

We think that Penumbra (NYSE: PEN), a medical devices company focused on interventional therapies, currently is a better pick compared to the Gap stock (NYSE: GPS), a specialty retailer selling casual apparel, accessories, and personal care products, despite it being the more expensive of the two…

Generated by Feedzy